Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis of liver cirrhosis
Wen-Ce Zhou
World Journal of Gastroenterology (2014) Vol. 20, Iss. 23, pp. 7312-7312
Open Access | Times Cited: 547

Showing 26-50 of 547 citing articles:

Immune Checkpoints and the Immunology of Liver Fibrosis
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
Livers (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access | Times Cited: 1
Liver-Derived Exosomes and Their Implications in Liver Pathobiology
Sumi Sung, Jieun Kim, Youngmi Jung
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3715-3715
Open Access | Times Cited: 80
Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach
Hong Chang, Hongyu Meng, Shumin Liu, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 77
Pathological process of liver sinusoidal endothelial cells in liver diseases
Yao Ni, Juan-Mei Li, Mingkun Liu, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 43, pp. 7666-7677
Open Access | Times Cited: 73
The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis
Kurt Sartorius, J. A. Makarova, Benn Sartorius, et al.
Cells (2019) Vol. 8, Iss. 12, pp. 1504-1504
Open Access | Times Cited: 71
Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis
Mattia Bellan, Micol Giulia Cittone, Stelvio Tonello, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 20, pp. 5070-5070
Open Access | Times Cited: 70
Next-Generation Liver Medicine Using Organoid Models
Soheil Akbari, Nur Arslan, Şerif Şentürk, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 66
Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways
Jiao Feng, Kan Chen, Yujing Xia, et al.
Drug Design Development and Therapy (2018) Vol. Volume 12, pp. 1837-1853
Open Access | Times Cited: 65
Modulation of inducible nitric oxide synthase pathway by eugenol and telmisartan in carbon tetrachloride-induced liver injury in rats
Moustafa Fathy, Esraa M.M.A. Khalifa, Michael Atef Fawzy
Life Sciences (2018) Vol. 216, pp. 207-214
Closed Access | Times Cited: 65
Oral Dysbiosis in Pancreatic Cancer and Liver Cirrhosis: A Review of the Literature
Hiba Mohammed, Elena Maria Varoni, Andrea Cochis, et al.
Biomedicines (2018) Vol. 6, Iss. 4, pp. 115-115
Open Access | Times Cited: 64
BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration
Blanca Herrera, Annalisa Addante, Aránzazu Sánchez
International Journal of Molecular Sciences (2017) Vol. 19, Iss. 1, pp. 39-39
Open Access | Times Cited: 62
Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis
Roman Maslennikov, Chavdar S Pavlov, В. Т. Ивашкин
Hepatology International (2018) Vol. 12, Iss. 6, pp. 567-576
Closed Access | Times Cited: 61
Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation
Marí­a José Rodrí­guez, Matías Sabaj, Gerardo Tolosa, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3406-3406
Open Access | Times Cited: 54
3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway
Ning Wang, Xiajing Li, Zhiyong Zhong, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 54
Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases
Xiaolin Xiao, Qichao Hu, Xinyu Deng, et al.
Pharmacological Research (2021) Vol. 175, pp. 106005-106005
Closed Access | Times Cited: 50
Hepatic Stellate Cell: A Double-Edged Sword in the Liver
Nianan Luo, J. Li, Yuhuan Wei, et al.
Physiological Research (2021), Iss. 6, pp. 821-829
Open Access | Times Cited: 41
Enterococcus raffinosus, Enterococcus durans and Enterococcus avium Isolated from a Tertiary Care Hospital in Romania—Retrospective Study and Brief Review
Dan Alexandru Țoc, Stanca Lucia Pandrea, Alexandru Botan, et al.
Biology (2022) Vol. 11, Iss. 4, pp. 598-598
Open Access | Times Cited: 30
Gut microbiome as a therapeutic target for liver diseases
Tejinder Pal Singh, Saurabh Kadyan, Harisha Devi, et al.
Life Sciences (2023) Vol. 322, pp. 121685-121685
Closed Access | Times Cited: 20
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis
Ruirui Zhu, Liwen Liu, Guizhen Zhang, et al.
Bioscience Reports (2023) Vol. 43, Iss. 6
Open Access | Times Cited: 20
Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challenges
Theerut Luangmonkong, Warisara Parichatikanond, Peter Olinga
Biochemical Pharmacology (2023) Vol. 215, pp. 115740-115740
Open Access | Times Cited: 20
Insights on drug and gene delivery systems in liver fibrosis
Kunj Vyas, Mayur M. Patel
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 2, pp. 100779-100779
Open Access | Times Cited: 19
Role of inflammasomes and cytokines in immune dysfunction of liver cirrhosis
Partha Pratim Das, Subhash Medhi
Cytokine (2023) Vol. 170, pp. 156347-156347
Closed Access | Times Cited: 18
Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?
Aneta Sokal, Sara Jarmakiewicz-Czaja, Katarzyna Ferenc, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5238-5238
Open Access | Times Cited: 7
Emerging role of liver-bone axis in osteoporosis
Hongliang Gao, Xing Peng, Ning Li, et al.
Journal of Orthopaedic Translation (2024) Vol. 48, pp. 217-231
Open Access | Times Cited: 7
Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review
Ernestina Santangeli, Chiara Abbati, Rusi Chen, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 427-427
Open Access | Times Cited: 6

Scroll to top